51 results
8-K
EX-10.1
BLPH
Bellerophon Therapeutics, Inc.
30 Jan 24
Entry into a Material Definitive Agreement
9:29am
the death, incapacity or bankruptcy of Subscriber. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties
8-K
BLPH
Bellerophon Therapeutics, Inc.
21 Nov 23
Departure of Directors or Certain Officers
12:00am
and thereafter until his successor has been elected and qualified or until his earlier death, resignation or removal. Mr. Jalbert has not been appointed to any
8-K
EX-10.1
BLPH
Bellerophon Therapeutics, Inc.
9 Jun 23
Departure of Directors or Certain Officers
4:05pm
due or exercise rights of the Participant in the event of the Participant’s death or (ii) in the absence of an effective designation by a Participant … of the disability, death, termination or other cessation of employment, authorized leave of absence or other change in the employment or other status
8-K
EX-99.2
BLPH
Bellerophon Therapeutics, Inc.
5 Jun 23
Bellerophon Announces Top-Line Data from Phase 3 REBUILD Clinical Trial of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease
8:08am
% Death 4.0% 4.3%
Investor Contacts Bellerophon Investor Relations BTInvestorRelations@bellerophon.com Brian Ritchie I LifeSci Advisors britchie@lifesciadvisors.com 212 - 915 - 2578
8-K
EX-99.1
8urian0tdwb
5 Jan 22
Company Presentation I January 2022Bellerophon Therapeutics
8:39am
8-K
EX-99.1
0f3l u93b
11 Jan 21
2021 Company Presentation I Company Presentation I January 2021 Bellerophon Therapeutics
8:01am
8-K
EX-99.1
ymjvl43 gp1n7v190
23 Nov 20
Bellerophon Therapeutics Announces Results of Interim Analysis of Phase 3 COViNOX Study of INOpulse® for the Treatment of COVID-19
8:33am
424B5
07hd5q4168
31 Mar 20
Prospectus supplement for primary offering
7:03am
8-K
EX-99.1
pl9c4au8ke ezew5i2k
20 Mar 20
Other Events
8:33am
424B5
2z25o9 8tpzancpijpk
23 Jan 19
Prospectus supplement for primary offering
5:14pm
424B5
9juvmjhh22v 4ef
23 Jan 19
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
b4kngyg7aubhcubh tud
7 Jan 19
Regulation FD Disclosure
8:40am
8-K
EX-99.1
6xhc8ul
16 Oct 18
Regulation FD Disclosure
8:18am